Alexey Sats

Mission MAHAlongevity’s mission is to re-establish U.S. leadership in stem cell medicine and healthy-longevity innovation. Today, overly restrictive FDA policies have driven nearly all clinical stem cell activity offshore—despite the fact that many of the world’s top stem cell scientists are American. Without urgent policy change, the United States risks permanent disconnection from the global stem cell ecosystem within the next decade. Advancing American leadership in longevity science #Healthspan #Longevity #StemCells #XPRIZE

Pioneering Generative AI Platform to Transform IP-Based Videos into Diverse Styles

CB Therapeutics is an innovative producer of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast, bacteria and cell-free expression systems. CB Therapeutics’ expertise in synthetic genomics, bio-engineering and cellular production processes can produce a broad range of phytochemicals faster, more sustainably, at greater yields and with higher purity, consistency and efficiency than competitive platforms. CB Therapeutics is focused on the discovery, research, development and production of tryptamines, cannabinoids and other molecules and compounds to advance Neuroscience and bring therapeutics to market to solve mankind’s most challenging mental healthcare and social problems.

Mission MAHAlongevity’s mission is to re-establish U.S. leadership in stem cell medicine and healthy-longevity innovation. Today, overly restrictive FDA policies have driven nearly all clinical stem cell activity offshore—despite the fact that many of the world’s top stem cell scientists are American. Without urgent policy change, the United States risks permanent disconnection from the global stem cell ecosystem within the next decade. Advancing American leadership in longevity science #Healthspan #Longevity #StemCells #XPRIZE

We are granting leading AI model teams and labs the rights to use the private datasets for fine-tuning “3 Body” models for free, with no upfront IP fee. These datasets include the original novel trilogy (which we already have), Tencents "Three-Body" TV series (to which we have access), and Netflixs "Three-Body Problem" TV series (currently in discussion). Our mission is to partner with SSI Lab (SSI Inc), founded by Ilya Sutskever, former co-founder and chief scientist of OpenAI, to build a safe superintelligence. The first step is to encourage all leading AI model teams and university labs to train billion-parameter models as many as possible. Then we will abstract them into one trillion-parameter model, UniverseOS™(BSF Lab’s first launch), with an open-source architecture that incorporates authorized private datasets from the Three-Body series. Finally, we will move into the Zeus Age—Three-Body Universe AGI, a safe superintelligence, around 2035.

Pioneering Generative AI Platform to Transform IP-Based Videos into Diverse Styles

CB Therapeutics is an innovative producer of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast, bacteria and cell-free expression systems. CB Therapeutics’ expertise in synthetic genomics, bio-engineering and cellular production processes can produce a broad range of phytochemicals faster, more sustainably, at greater yields and with higher purity, consistency and efficiency than competitive platforms. CB Therapeutics is focused on the discovery, research, development and production of tryptamines, cannabinoids and other molecules and compounds to advance Neuroscience and bring therapeutics to market to solve mankind’s most challenging mental healthcare and social problems.